Currently, an ongoing phase III, multicenter, randomized, sham-controlled, double-blind trial is evaluating AT-04s efficacy and safety for endometriosis-related pain (dysmenorrhea, dyspareunia, chronic pelvic pain), with the primary outcome being the change in Numeric Rating Scale score at 16 weeks ( 4.5 Disease heterogeneity and subtype-specific therapeutic strategies Endometriosis exhibits significant clinical and biological heterogeneity, encompassing diverse anatomical subtypessuperficial peritoneal endometriosis (SPE), ovarian endometriomas (OMA), and deep infiltrating endometriosis (DIE)each with distinct pathophysiological features, symptom profiles, and fertility implications ( Table 1 )
Mediation analysis further demonstrated that total protein and glutamate dehydrogenase may influence cognitive function by mediating AD pathological alterations [31]
Temperature acclimation before drawing doses Cold solution drawn directly from the refrigerator is more viscous than room-temperature solution
A: When taken as directed under professional guidance, side effects are rare